SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-033516
Filing Date
2019-05-30
Accepted
2019-05-30 18:16:33
Documents
1
Period of Report
2019-05-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6700
  Complete submission text file 0001209191-19-033516.txt   8214
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Issuer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CARA THERAPEUTICS, INC. 1 PARROTT DRIVE SHELTON CT 06484
Business Address
Menzaghi Frederique Ph.D. (Reporting) CIK: 0001597152 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36279 | Film No.: 19867959